These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry. Gitt AK, Juenger C, Jannowitz C, Karmann B, Senges J, Bestehorn K. Eur J Cardiovasc Prev Rehabil; 2009 Aug 05; 16(4):438-44. PubMed ID: 19369876 [Abstract] [Full Text] [Related]
12. Comparison of flow-mediated dilatation of the brachial artery in coronary patients with low-density lipoprotein cholesterol levels <80 mg/dl versus patients with levels 80 to 100 mg/dl. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Karas RH. Am J Cardiol; 2005 Jan 01; 95(1):93-5. PubMed ID: 15619399 [Abstract] [Full Text] [Related]
13. Insulin resistance phenotypes and coronary artery disease in a native Pakistani cohort. Wierzbicki AS, Nishtar S, Lumb PJ, Lambert-Hammill M, Crook MA, Marber MS, Gill J. Int J Clin Pract; 2008 May 01; 62(5):701-7. PubMed ID: 18341566 [Abstract] [Full Text] [Related]
16. Halting the progression of atherosclerosis with intensive lipid lowering: results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. Nissen SE. Am J Med; 2005 Dec 01; 118 Suppl 12A():22-7. PubMed ID: 16356804 [Abstract] [Full Text] [Related]
17. Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease. Ogasawara K, Mashiba S, Hashimoto H, Kojima S, Matsuno S, Takeya M, Uchida K, Yajima J. Clin Chim Acta; 2008 Nov 01; 397(1-2):42-7. PubMed ID: 18691566 [Abstract] [Full Text] [Related]